Post-refractive IOL Outcomes With Clareon TruPlus
Recruiting
Observational Study
Cataract
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 35 (estimated)
- Sponsor
- Laser Defined Vision · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Willing and able to understand and sign informed consent.
* Adult patients (\>45 years old) undergoing age-related cataract surgery that previously had myopic corneal refractive surgery.
* Dominant eye targeted for emmetropia, non-dominant eye may be targeted for ≤-0.75D (mini…
Contacts
No contact information available.